Investigation of computed tomography findings of portal hypertension at non-alcoholic fatty liver disease

被引:0
|
作者
Kulali, Fatma [1 ]
Kaya-Tuna, Burcu [1 ]
Semiz-Oysu, Aslihan [1 ]
Kilicoglu, Zeynep Gamze [2 ]
Bukte, Yasar [1 ]
机构
[1] Umraniye Training & Res Hosp, Istanbul, Turkey
[2] Haydarpasa Numune Training & Res Hosp, Istanbul, Turkey
关键词
Hepatosteatosis; Portal hypertension; Fatty liver; Cirrhosis;
D O I
10.1016/j.ejrnm.2016.05.012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Non-alcoholic fatty liver disease (NAFLD) is very common and serious disease. It begins as a simple hepatosteatosis but can progress to cirrhosis. The early detection of portal hypertension (HT) can be helpful in the management of these patients. Aims: To evaluate radiologic findings of portal hypertension at computed tomography (CT) of patients with non-alcoholic fatty liver disease for early diagnosis. Methods and materials: Images of 225 cases who underwent non-enhanced abdominal CT were reviewed. The patients with the difference between hepatic and splenic attenuation (CT L-S) > 10 were enrolled in hepatosteatosis group. The remainings formed control group. The relationship between two groups about diameters of portal and splenic veins, craniocaudal (CC) span of liver, splenic index, caudate lobe/right lobe (C/RL) ratio was analyzed statistically by Mann-Whitney U Test and Student's t-test. Results: Total 213 cases, as hepatosteatosis (n = 149) and control (n = 64) groups, were involved in this study. Liver CC span, splenic index and C/RL ratio between two groups were found to be statistically significant (p < 0.01). Conclusions: The splenic index and C/RL ratio are important findings of portal HT and fibrosis. CT imaging can be beneficial for diagnosis and treatment of NAFLD patients. (C) 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [31] Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease
    Andrea Tannapfel
    Helmut Denk
    Hans-Peter Dienes
    Cord Langner
    Peter Schirmacher
    Michael Trauner
    Berenike Flott-Rahmel
    Virchows Archiv, 2011, 458 : 511 - 523
  • [32] Non-invasive tests of non-alcoholic fatty liver disease
    Li Guanlin
    Zhang Xinrong
    Lin Huapeng
    Liang Lilian Yan
    Wong Grace Lai-Hung
    Wong Vincent Wai-Sun
    中华医学杂志英文版, 2022, 135 (05) : 532 - 546
  • [33] Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)
    Choudhary, Narendra Singh
    Duseja, Ajay
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [34] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [35] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children
    Kodhelaj, K.
    Resuli, B.
    Petrela, E.
    Malaj, V.
    Jaze, H.
    MINERVA PEDIATRICA, 2014, 66 (01) : 23 - 30
  • [36] Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
    Song, Byeong Geun
    Kang, Tae Wook
    Sinn, Dong Hyun
    Kim, Yeun-Yoon
    Min, Ji Hye
    Hwang, Jeong Ah.
    Shin, Jaeseung
    CLINICAL IMAGING, 2024, 108
  • [37] Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease
    Razavizade, Mohsen
    Jamali, Raika
    Arj, Abbas
    Talari, Hamidreza
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (05) : 513 - 520
  • [38] Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (10) : 527 - 535
  • [39] Serum parameters predict the severity of ultrasonographic findings in non-alcoholic fatty liver disease
    Mohsen Razavizade
    Raika Jamali
    Abbas Arj
    Hamidreza Talari
    Hepatobiliary&PancreaticDiseasesInternational, 2012, 11 (05) : 513 - 520
  • [40] Non-alcoholic fatty liver disease and cardiovascular risk
    Brea, Angel
    Puzo, Jose
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 167 (04) : 1109 - 1117